Common Contracts

2 similar Merger Agreement contracts by G1 Therapeutics, Inc., Prevail Therapeutics Inc.

AGREEMENT AND PLAN OF MERGER among PHARMACOSMOS A/S, GENESIS MERGER SUB, INC. and G1 THERAPEUTICS, INC. Dated as of August 6, 2024
Merger Agreement • August 7th, 2024 • G1 Therapeutics, Inc. • Pharmaceutical preparations • Delaware

AGREEMENT AND PLAN OF MERGER, dated as of August 6, 2024 (this “Agreement”), among Pharmacosmos A/S, a Danish Aktieselskab (“Parent”), Genesis Merger Sub, Inc., a Delaware corporation and indirectly wholly owned Subsidiary of Parent (“Purchaser”), and G1 Therapeutics, Inc., a Delaware corporation (the “Company”).

AGREEMENT AND PLAN OF MERGER among ELI LILLY AND COMPANY, TYTO ACQUISITION CORPORATION, and PREVAIL THERAPEUTICS INC. Dated as of December 14, 2020
Merger Agreement • December 15th, 2020 • Prevail Therapeutics Inc. • Biological products, (no disgnostic substances) • Delaware

AGREEMENT AND PLAN OF MERGER, dated as of December 14, 2020 (this “Agreement”), among Eli Lilly and Company, an Indiana corporation (“Parent”), Tyto Acquisition Corporation, a Delaware corporation and wholly owned Subsidiary of Parent (“Purchaser”), and Prevail Therapeutics Inc., a Delaware corporation (the “Company”).